SCHEMBL12856857

SCHEMBL12856857

CCCOc1c2cccc1Cc1cccc(c1OCCC)Cc1cccc(c1OCCC)Cc1cccc(c1OCCC)C2

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSTA1 P08263 6/20 0.56
GSTP1 P09211 6/20 0.56
PTPRC P08575 4/20 0.56
PTPN2 P17706 4/20 0.56
PTPN1 P18031 4/20 0.56
PTPRB P23467 4/20 0.56
PTPN11 Q06124 4/20 0.56
CD69 Q07108 2/20 0.50
TLR4 O00206 1/20 0.43
CD14 P08571 1/20 0.43
LY96 Q9Y6Y9 1/20 0.43
LGALS1 P09382 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.38
KMT2A Q03164 2/20 0.37
CHRM2 P08172 2/20 0.36
LMNA P02545 1/20 0.36
CHRM1 P11229 1/20 0.36
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36
ACHE P22303 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31326111 1.00 GSTA1 (0.56) GSTA1GSTP1PTPRCPTPN2PTPN1
SCHEMBL12856732 0.91 GSTA1 (0.67) GSTA1GSTP1PTPRCPTPN2PTPN1
SCHEMBL6067606 0.89 GSTA1 (0.57) GSTA1GSTP1PTPRCPTPN2PTPN1
SCHEMBL30702676 0.89 GSTA1 (0.57) GSTA1GSTP1PTPRCPTPN2PTPN1
SCHEMBL5021866 0.88 GSTA1 (0.51) GSTA1GSTP1PTPRCPTPN2PTPN1
SCHEMBL6202528 0.87 PTPRC (0.53) GSTA1GSTP1PTPRCPTPN2PTPN1
SCHEMBL6203943 0.85 GSTA1 (0.46) GSTA1GSTP1PTPRCPTPN2PTPN1
SCHEMBL12856718 0.83 GSTA1 (0.64) GSTA1GSTP1PTPRCPTPN2PTPN1
SCHEMBL19726834 0.83 GSTA1 (0.64) GSTA1GSTP1PTPRCPTPN2PTPN1
SCHEMBL12856777 0.82 GSTA1 (0.63) GSTA1GSTP1PTPRCPTPN2PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110028676-A1 Molecular Actuators, and Methods of Use Thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2011-02-03 US disclosed
US-7658868-B2 Class of molecular actuators where bulk actuation mechanisms such as ion intercalation are enhanced by controllable single molecule conformational rearrangements offers promise in exhibiting large active strains at moderate stresses MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2010-02-09 US disclosed
US-20070215839-A1 Molecular actuators, and methods of use thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2007-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070215839-A1 Molecular actuators, and methods of use thereof NOD2, PIEZO1, TPR GSTA1 969/4885GSTP1 150/4885PTPRC 1115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.